GlassScriptPhysician profile
Johnstone M Kim
NPI 1982880605
$9,993.16
in general payments reported to CMS, 2019-2025
16 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,027 · 2020: $1,363 · 2021: $2,389 · 2022: $3,754 · 2023: $230 · 2024: $71.00 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Retina LLC | $8,738.12 | 2019-2022 | |
| Allergan, INC. | $203.65 | 2019-2021 | |
| Alimera Sciences, INC. | $181.77 | 2019-2023 | Iluvien |
| Dutch Ophthalmic, USA | $177.08 | 2019 | |
| Genentech, INC. | $126.33 | 2023 | Vabysmo, Susvimo |
| Apellis Pharmaceuticals, INC. | $101.36 | 2024-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $98.79 | 2019-2023 | Eylea |
| Genentech USA, INC. | $79.86 | 2023-2025 | Vabysmo |
| Abbvie INC. | $69.20 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $66.59 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.10 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.76 | 2025 | Jardiance |
| Horizon Therapeutics Plc | $30.12 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $19.30 | 2021 | |
| Alcon Vision LLC | $16.38 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$314,621.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnstone Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.